Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

Autoria(s): O'Harte, F.P.M.; Gault, V.A.; Harriott, Patrick; Green, Brian; Flatt, P.R.
Data(s)

2002
Identificador

http://pure.qub.ac.uk/portal/en/publications/comparative-studies-with-exendin939amide-and-the-novel-pro3gip-receptor-antagonist-indicates-that-glucosedependent-insulinotropic-polypeptide-is-the-major-hormone-of-the-enteroinsular-axis(c4422269-bf21-4bd3-9b96-2912793ecc9a).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

O'Harte , F P M , Gault , V A , Harriott , P , Green , B & Flatt , P R 2002 , ' Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis. ' Diabetologia , vol 45 , no. S2 , A178 .
Tipo

article
Acesso ao item digital